Meeting
2023 ASCO Annual Meeting
The genomic, transcriptomic, and immunological landscape of TROP2 in solid tumors.
Authors
Asaad Trabolsi
Jackson Memorial Hospital/ University of Miami, Miami, FL
Asaad Trabolsi , Samuel A. Kareff , Estelamari Rodriguez , Harris Benjamin Krause , Heng Tan , Dan Morgenstern-Kaplan , Emmanuel S. Antonarakis , Emil Lou , Misako Nagasaka , Sandra Algaze , Heinz-Josef Lenz , Stephen V. Liu , Balazs Halmos , Dave S. Hoon , Andreas Seeber , Patrick C. Ma , Wafik S. El-Deiry , Ari M. Vanderwalde , George W. Sledge Jr., Gilberto Lopes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Tissue-Based Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3118)
DOI
10.1200/JCO.2023.41.16_suppl.3118
Abstract #
3118
Poster Bd #
316
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The genomic, transcriptomic, and immunologic landscape in solid tumors expressing leukocyte immunoglobulin-like receptor B2 (LILRB2).
First Author: Sandra Jones
Poster
2023 ASCO Annual Meeting
The genomic, transcriptomic, and immunological landscape of SGLT2 in lung cancer.
First Author: Heng Tan
Poster
2022 ASCO Annual Meeting
Comprehensive genomic and transcriptomic characterization of small bowel adenocarcinoma.
First Author: Karan Pandya
Poster
2021 ASCO Annual Meeting
Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung.
First Author: Chul Kim